Physician profile
Joanna Slusky
NPI 1366757320
$13,829.34
in general payments reported to CMS, 2019-2025
23 companies · $955 in 2025
The $955 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,178 · 2020: $539 · 2021: $631 · 2022: $2,118 · 2023: $5,973 · 2024: $2,435 · 2025: $955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,834 · Travel and Lodging: $2,529 · Gift: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,833.75 |
| Travel and Lodging | $2,529.23 |
| Gift | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $4,045.32 | 2019-2025 | Cvi Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $3,567.84 | 2019-2025 | Acuvue |
| Lumenis Be INC | $1,653.81 | 2024 | M22 |
| Alcon Vision LLC | $1,602.20 | 2021-2025 | Precision 1, Precision7, Total30 |
| Bausch & Lomb Americas INC. | $904.33 | 2022-2025 | Infuse, Biotrue, Vyzulta |
| Abb Con-Cise Optical Group LLC | $494.29 | 2019-2023 | Spectacle Lenses, Contact Lens |
| Sight Sciences, INC. | $218.72 | 2019-2024 | Tearcare System |
| Eyevance Pharmaceuticals LLC | $217.15 | 2019-2021 | |
| Biotissue Holdings INC. | $209.37 | 2019-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $200.60 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $121.80 | 2024 | Nuzyra |
| Horizon Therapeutics Plc | $117.70 | 2022 | |
| Oyster Point Pharma, INC. | $97.93 | 2022 | |
| Novartis Pharmaceuticals Corporation | $85.75 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $65.49 | 2019-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $38.74 | 2022 | |
| Tearlab Corp | $36.95 | 2022-2024 | Scoutpro Osmolarity System |
| Tarsus Pharmaceuticals, INC. | $36.21 | 2025 | Xdemvy |
| Dompe US, INC. | $29.53 | 2025 | Oxervate |
| Abbvie INC. | $27.14 | 2022 | |
| Glaukos Corporation | $22.58 | 2024 | Radius |
| Allergan, INC. | $20.12 | 2022 | |
| Quidel Corporation | $15.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanna Slusky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.